+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Continuous Bioprocessing Market by Product, Process, Application, Scale of Operation, End-User - Global Forecast 2025-2030- Product Image
Continuous Bioprocessing Market by Product, Process, Application, Scale of Operation, End-User - Global Forecast 2025-2030- Product Image
Sale

Continuous Bioprocessing Market by Product, Process, Application, Scale of Operation, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5012940
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Continuous Bioprocessing Market grew from USD 233.44 million in 2023 to USD 282.42 million in 2024. It is expected to continue growing at a CAGR of 21.30%, reaching USD 902.23 million by 2030.

Continuous bioprocessing is an innovative method in biotechnology that integrates the discovery, development, production, and delivery of biologics, pharmaceuticals, and other products on a continuous basis, replacing traditional batch processing. This approach is essential for increasing productivity, reducing costs, and enhancing flexibility and efficiency in biomanufacturing, offering significant benefits over conventional methods. Applications span across pharmaceuticals, particularly in mAbs (monoclonal antibodies), vaccines, and gene therapy production, as well as in the food and agriculture industries. The end-use scope includes biopharmaceutical companies, academic and research institutions, and contract manufacturing organizations. Key growth factors influencing the market include the rising demand for biologics, regulatory support for advanced manufacturing technologies, and the need for cost-effective solutions. The latest opportunities arise from technological advancements such as perfusion systems, single-use technologies, and automation, highlighting a trend toward miniaturization and integration of bioprocessing steps. To capitalize on these opportunities, firms must invest in flexible platforms ensuring scalability and adaptability to diverse bioproducts.

However, market growth faces limitations such as high initial capital investment, technical challenges associated with integrating continuous processes, and a skill gap in handling advanced technologies. Moreover, regulatory complexities may pose compliance challenges for widespread adoption. Exploring innovative areas like cell culture optimization, process analytics technologies, and digital transformation with AI and machine learning can drive business growth. Research focusing on enhancing process understanding and control will provide valuable insights for further refinement. The market is characterized by rapid technological evolution, with stakeholders increasingly collaborating to overcome challenges. Businesses aligning with this transformative shift by investing in emerging technologies and strategic partnerships will harness new growth trajectories in continuous bioprocessing.

Understanding Market Dynamics in the Continuous Bioprocessing Market

The Continuous Bioprocessing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing demand for biopharmaceuticals & government support for the industry
    • Increased benefits over batch processing & uptake of single-use technology
    • Advent of industry 4.0 & trend towards automation & digitization
  • Market Restraints
    • Strict regulations for continuous bioprocessing coupled with high equipment cost
  • Market Opportunities
    • Adoption of perfusion associated with single-use equipment
    • Development of a continuous bioprocessing approach to stromal cell manufacturing
  • Market Challenges
    • Issues with operational difficulties and process changes

Exploring Porter’s Five Forces for the Continuous Bioprocessing Market

Porter’s Five Forces framework further strengthens the insights of the Continuous Bioprocessing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Continuous Bioprocessing Market

External macro-environmental factors deeply influence the performance of the Continuous Bioprocessing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Continuous Bioprocessing Market

The Continuous Bioprocessing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Continuous Bioprocessing Market

The Continuous Bioprocessing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Continuous Bioprocessing Market

The Continuous Bioprocessing Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Continuous Bioprocessing Market, highlighting leading vendors and their innovative profiles. These include 3D Biotek LLC, 3M Company, Adolf Kühner AG, bbi-biotech GmbH, Belach Bioteknik AB, Bio-Rad Laboratories, Inc., Bionet Servicios Técnicos S.L., Colder Products Company, Danaher Corporation, Esco Aster Pte Ltd., Esco VacciXcell, FiberCell Systems Inc., Fujifilm Holdings Corporation, GE HealthCare Technologies Inc., GEA Group, Getinge AB, Infors AG, Merck KGaA, Repligen Corporation, Sartorius AG, simAbs NV, Suzhou Transcenta Therapeutics Co., Ltd., Thermo Fisher Scientific Inc., Watson-Marlow Fluid Technology Group, and WuXi Biologics Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Continuous Bioprocessing Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Bioreactors
    • Cell Culture Media & Reagent
    • Centrifuges
    • Chromatography System
    • Filtration Systems
    • Incubators & Shakers
  • Process
    • Downstream Bioprocess
    • Upstream Bioprocess
  • Application
    • Cell & Gene Therapy
    • Monoclonal Antibodies
    • Vaccines
  • Scale of Operation
    • Clinical Operations
    • Commercial Operations
  • End-User
    • Academic & Research Institutes
    • Contract Development & Manufacturing Organizations
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand for biopharmaceuticals & government support for the industry
5.1.1.2. Increased benefits over batch processing & uptake of single-use technology
5.1.1.3. Advent of industry 4.0 & trend towards automation & digitization
5.1.2. Restraints
5.1.2.1. Strict regulations for continuous bioprocessing coupled with high equipment cost
5.1.3. Opportunities
5.1.3.1. Adoption of perfusion associated with single-use equipment
5.1.3.2. Development of a continuous bioprocessing approach to stromal cell manufacturing
5.1.4. Challenges
5.1.4.1. Issues with operational difficulties and process changes
5.2. Market Segmentation Analysis
5.2.1. Product: Growing preference for bioreactors in large-scale production of recombinant proteins
5.2.2. Process: Rising usage of upstream processes owing to progress in terms of efficiency and capacity
5.2.3. Application: Extensive utilization of continuous bioprocessing in the vaccine industry to improve public health
5.2.4. Scale of Operation: Growing application of continuous bioprocessing in the clinical operations
5.2.5. End-User: Significant role of continuous bioprocessing in CDMO as they prioritize flexibility and service offering enhancements for their clients
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Continuous Bioprocessing Market, by Product
6.1. Introduction
6.2. Bioreactors
6.3. Cell Culture Media & Reagent
6.4. Centrifuges
6.5. Chromatography System
6.6. Filtration Systems
6.7. Incubators & Shakers
7. Continuous Bioprocessing Market, by Process
7.1. Introduction
7.2. Downstream Bioprocess
7.3. Upstream Bioprocess
8. Continuous Bioprocessing Market, by Application
8.1. Introduction
8.2. Cell & Gene Therapy
8.3. Monoclonal Antibodies
8.4. Vaccines
9. Continuous Bioprocessing Market, by Scale of Operation
9.1. Introduction
9.2. Clinical Operations
9.3. Commercial Operations
10. Continuous Bioprocessing Market, by End-User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Contract Development & Manufacturing Organizations
10.4. Pharmaceutical & Biotechnology Companies
11. Americas Continuous Bioprocessing Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Continuous Bioprocessing Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Continuous Bioprocessing Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of ~6 g/L/day at Pilot Scale
14.3.2. Sartorius and Repligen Launch Integrated Bioreactor System
14.3.3. 3M To Invest Nearly USD 150 Million To Advance Capabilities In Biopharma Filtration Technology
14.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. CONTINUOUS BIOPROCESSING MARKET RESEARCH PROCESS
FIGURE 2. CONTINUOUS BIOPROCESSING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 15. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. CONTINUOUS BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. CONTINUOUS BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CONTINUOUS BIOPROCESSING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CONTINUOUS BIOPROCESSING MARKET DYNAMICS
TABLE 7. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL CULTURE MEDIA & REAGENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY INCUBATORS & SHAKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL & GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CLINICAL OPERATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL OPERATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 46. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 48. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 51. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 53. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. CHINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. CHINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 73. CHINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. CHINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 75. CHINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. INDIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. INDIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 78. INDIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. INDIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 80. INDIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. JAPAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. JAPAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 88. JAPAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. JAPAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 90. JAPAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. THAILAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. THAILAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 118. THAILAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. THAILAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 120. THAILAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 132. DENMARK CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. DENMARK CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 134. DENMARK CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. DENMARK CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 136. DENMARK CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. EGYPT CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. EGYPT CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 139. EGYPT CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. EGYPT CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 141. EGYPT CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. FINLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. FINLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 144. FINLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. FINLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 146. FINLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. FRANCE CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. FRANCE CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 149. FRANCE CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. FRANCE CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 151. FRANCE CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 154. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 156. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. ITALY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. ITALY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 164. ITALY CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. ITALY CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 166. ITALY CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. NORWAY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. NORWAY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 179. NORWAY CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. NORWAY CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 181. NORWAY CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. POLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. POLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 184. POLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. POLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 186. POLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. QATAR CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. QATAR CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 189. QATAR CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. QATAR CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 191. QATAR CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. SPAIN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. SPAIN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 209. SPAIN CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. SPAIN CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 211. SPAIN CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 222. TURKEY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 223. TURKEY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 224. TURKEY CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. TURKEY CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 226. TURKEY CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 237. CONTINUOUS BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 238. CONTINUOUS BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Continuous Bioprocessing Market, which are profiled in this report, include:
  • 3D Biotek LLC
  • 3M Company
  • Adolf Kühner AG
  • bbi-biotech GmbH
  • Belach Bioteknik AB
  • Bio-Rad Laboratories, Inc.
  • Bionet Servicios Técnicos S.L.
  • Colder Products Company
  • Danaher Corporation
  • Esco Aster Pte Ltd.
  • Esco VacciXcell
  • FiberCell Systems Inc.
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • GEA Group
  • Getinge AB
  • Infors AG
  • Merck KGaA
  • Repligen Corporation
  • Sartorius AG
  • simAbs NV
  • Suzhou Transcenta Therapeutics Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • Watson-Marlow Fluid Technology Group
  • WuXi Biologics Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 282.42 Million
Forecasted Market Value ( USD ) by 2030 $ 902.23 Million
Compound Annual Growth Rate21.3%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Continuous Bioprocessing Market by Product (Chromatography, Filtration, Bioreactor, Media), Process (Upstream, Downstream), Scale of Operation (Commercial, Clinical), Application (mAbs, Vaccines, Cell & Gene Therapy), End-user, and Region - Forecast to 2028 - Product Image

Continuous Bioprocessing Market by Product (Chromatography, Filtration, Bioreactor, Media), Process (Upstream, Downstream), Scale of Operation (Commercial, Clinical), Application (mAbs, Vaccines, Cell & Gene Therapy), End-user, and Region - Forecast to 2028

  • Report
  • 263 Pages
  • Global
From
Upstream Bioprocessing Market Size, Share & Trends Analysis Report by Product (Bioreactors/Fermenters, Cell Culture Products), Workflow (Media Preparation, Cell Culture), Use Type (Multi-use, Single-use), Mode, Region, and Segment Forecasts, 2024-2030 - Product Image

Upstream Bioprocessing Market Size, Share & Trends Analysis Report by Product (Bioreactors/Fermenters, Cell Culture Products), Workflow (Media Preparation, Cell Culture), Use Type (Multi-use, Single-use), Mode, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Single-use Bioprocessing Market by Product, Workflow, Application, End-User - Global Forecast 2025-2030 - Product Image

Single-use Bioprocessing Market by Product, Workflow, Application, End-User - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Upstream Bioprocessing Market by Product, Workflow, Use Type, Mode - Global Forecast 2025-2030 - Product Image

Upstream Bioprocessing Market by Product, Workflow, Use Type, Mode - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Continuous Bioprocessing Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F - Product Image

Continuous Bioprocessing Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.